292 related articles for article (PubMed ID: 34952974)
21. Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
Liu J; Wang Y; Guo W; Cheng Y; Zhang S; Wu B; Liu M
Int J Cardiol; 2021 Jan; 322():258-264. PubMed ID: 32814110
[TBL] [Abstract][Full Text] [Related]
22. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.
Baturova MA; Lindgren A; Carlson J; Shubik YV; Bertil Olsson S; Platonov PG
Int J Cardiol; 2017 Apr; 232():134-139. PubMed ID: 28132778
[TBL] [Abstract][Full Text] [Related]
23. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
[No Abstract] [Full Text] [Related]
24. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
[TBL] [Abstract][Full Text] [Related]
25. Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study.
Chang SS; Dong JZ; Ma CS; Du X; Wu JH; Tang RB; Xia SJ; Guo XY; Yu RH; Long DY; Bai R; Liu N; Sang CH; Jiang CX; Liu XH; Pan JH; Lip GY
Stroke; 2016 Jul; 47(7):1803-10. PubMed ID: 27283198
[TBL] [Abstract][Full Text] [Related]
26. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
[TBL] [Abstract][Full Text] [Related]
27. A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF).
Kim H; Lee YS; Kim TH; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Shim J; Uhm JS; Park HW; Choi EK; Kim JB; Kim C; Kim J; Joung B
Korean J Intern Med; 2020 Jan; 35(1):99-108. PubMed ID: 31014064
[TBL] [Abstract][Full Text] [Related]
28. Clinical analysis of antithrombotic treatment and occurrence of stroke in elderly patients with nonvalvular persistent atrial fibrillation.
Yu LJ; Chen S; Xu Y; Zhang ZX
Clin Cardiol; 2018 Oct; 41(10):1353-1357. PubMed ID: 30141193
[TBL] [Abstract][Full Text] [Related]
29. Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
Martinez BK; Baker WL; Sood NA; Bunz TJ; Meinecke AK; Eriksson D; Coleman CI
Pharmacotherapy; 2019 Feb; 39(2):196-203. PubMed ID: 30597611
[TBL] [Abstract][Full Text] [Related]
30. Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry.
Cools F; Johnson D; Camm AJ; Bassand JP; Verheugt FWA; Yang S; Tsiatis A; Fitzmaurice DA; Goldhaber SZ; Kayani G; Goto S; Haas S; Misselwitz F; Turpie AGG; Fox KAA; Pieper KS; Kakkar AK;
J Thromb Haemost; 2021 Sep; 19(9):2322-2334. PubMed ID: 34060704
[TBL] [Abstract][Full Text] [Related]
31. Oral anti-coagulants use in Chinese hospitalized patients with atrial fibrillation.
Lin J; Long D; Jiang C; Sang C; Tang R; Li S; Wang W; Guo X; Ning M; Sun Z; Yang N; Hao Y; Liu J; Liu J; Du X; Morgan L; Fonarow GC; Smith SC; Lip GYH; Zhao D; Dong J; Ma C;
Chin Med J (Engl); 2024 Jan; 137(2):172-180. PubMed ID: 38146256
[TBL] [Abstract][Full Text] [Related]
32. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
33. Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke.
Kim JM; Park KY; Yu IW; Song TJ; Kim YJ; Kim BJ; Heo SH; Jung JM; Oh KM; Kim CK; Yu S; Park JH; Choi JC; Park MS; Kim JT; Choi KH; Hwang YH; Chung JW; Bang OY; Kim GM; Seo WK
Eur J Neurol; 2020 May; 27(5):900-902. PubMed ID: 32064742
[TBL] [Abstract][Full Text] [Related]
34. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry.
Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: A retrospective multicenter case-control study.
Zhao J; Zhang Y; Yuan F; Song C; Jiang Y; Gao Q; Leng X; Jiang W
J Neurol Sci; 2020 Jul; 414():116822. PubMed ID: 32278166
[TBL] [Abstract][Full Text] [Related]
36. Trends in preadmission oral anticoagulant use and clinical outcome in atrial fibrillation patients admitted with acute stroke in Denmark.
Larsen LK; Ovesen C; Frost L; Damgaard D; Christensen H; Johnsen SP
Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):112-120. PubMed ID: 31855254
[TBL] [Abstract][Full Text] [Related]
37. Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation.
Saeed O; Zhang S; Patel SR; Jorde UP; Garcia MJ; Bulcha N; Gupta T; Xian Y; Matsouaka R; Shah S; Smith EE; Schwamm LH; Fonarow GC
J Card Fail; 2021 Aug; 27(8):857-864. PubMed ID: 33975786
[TBL] [Abstract][Full Text] [Related]
38. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
39. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
[TBL] [Abstract][Full Text] [Related]
40. Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
Tanaka K; Koga M; Lee KJ; Kim BJ; Park EL; Lee J; Mizoguchi T; Yoshimura S; Cha JK; Lee BC; Nakahara J; Suzuki N; Bae HJ; Toyoda K;
Stroke; 2020 Apr; 51(4):1150-1157. PubMed ID: 32098607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
